Egypt's Minapharm Pharmaceuticals sees $6.50mln block trading deal
The deal saw the trading of 1.23mln shares
Islam Magdy, an owner of a medical supplies shop, sits beside a variety of protective face masks to prevent the spread of the new coronavirus disease (COVID-19) in downtown Cairo, after Egypt's government made wearing masks mandatory in public places and on public transport, in Cairo, Egypt May 31, 2020. Image used for illustrative purpose.
REUTERS/Amr Abdallah Dalsh
By Staff Writer, Mubasher
Cairo – The Egyptian Exchange (EGX) announced that a block-trading transaction was executed on the shares of Minapharm Pharmaceuticals.
The deal saw the trading of 1.23 million shares at a total value of EGP 104.43 million, according to a statement on Sunday.
It is noteworthy to mention that during the first quarter of 2020, Minapharm Pharmaceuticals posted net profits of EGP 75.25 million, up from EGP 42.42 million in the prior-year period, including minority shareholders’ rights.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW